Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Kennedy

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Cityscape (Washington, D.C.)|May 23, 2022
Toward a Cross-Platform Framework: Assessing the Comprehensiveness of Online Rental ListingsAna Costa, Victoria Sass, Ian Kennedy, et al.
International Journal of Toxicology|January 18, 2014
Combustion By-Products and their Health Effects--combustion engineering and global health in the 21st century: issues and challengesSlawo Lomnicki, Brian Gullett, Tobias Stöger, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2021
Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PETMichael D Devous, Adam S Fleisher, Michael J Pontecorvo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2018
Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scaleMichael Navitsky, Abhinay D Joshi, Ian Kennedy, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 15, 2026
Interchangeability of CSF and PET to identify Alzheimer's disease pathologySamantha C Burnham, Anupa K Arora, Leonardo Iaccarino, et al.
Journal of the National Cancer Institute|July 22, 2004
Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trialRobert C F Leonard, Michael Lind, Christopher Twelves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trialJean-Marc Nabholtz, Carla Falkson, Daniel Campos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2025
Correction to: Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [<sup>18</sup>F]flortaucipir imaging: TAU-SPEXEmma M Coomans, Bastiaan van Tol, Colin Groot, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2025
Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [<sup>18</sup>F]flortaucipir imaging: TAU-SPEXEmma M Coomans, Bastiaan van Tol, Colin Groot, et al.
Brain : a Journal of Neurology|April 23, 2019
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementiaMichael J Pontecorvo, Michael D Devous, Ian Kennedy, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Cityscape (Washington, D.C.)|May 23, 2022
Toward a Cross-Platform Framework: Assessing the Comprehensiveness of Online Rental ListingsAna Costa, Victoria Sass, Ian Kennedy, et al.
International Journal of Toxicology|January 18, 2014
Combustion By-Products and their Health Effects--combustion engineering and global health in the 21st century: issues and challengesSlawo Lomnicki, Brian Gullett, Tobias Stöger, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2021
Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PETMichael D Devous, Adam S Fleisher, Michael J Pontecorvo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2018
Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scaleMichael Navitsky, Abhinay D Joshi, Ian Kennedy, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 15, 2026
Interchangeability of CSF and PET to identify Alzheimer's disease pathologySamantha C Burnham, Anupa K Arora, Leonardo Iaccarino, et al.
Journal of the National Cancer Institute|July 22, 2004
Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trialRobert C F Leonard, Michael Lind, Christopher Twelves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trialJean-Marc Nabholtz, Carla Falkson, Daniel Campos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2025
Correction to: Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [<sup>18</sup>F]flortaucipir imaging: TAU-SPEXEmma M Coomans, Bastiaan van Tol, Colin Groot, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2025
Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [<sup>18</sup>F]flortaucipir imaging: TAU-SPEXEmma M Coomans, Bastiaan van Tol, Colin Groot, et al.
Brain : a Journal of Neurology|April 23, 2019
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementiaMichael J Pontecorvo, Michael D Devous, Ian Kennedy, et al.
Pageof 7